Citations

Institution: Mayo Clinic Clear

Showing 10 of 108104 citations.

Proximal femoral density distribution and structure in relation to age and hip fracture risk in women
Carballido‐Gamio, Julio , Harnish, Roy, Saeed, Isra, Streeper, T., Sigurðsson, Sigurður , Amin, Shreyasee , Atkinson, Elizabeth J. , Therneau, Terry M. , Siggeirsdóttir, Kristín , Melton, L. Joseph , Keyak, Joyce H. , Guðnason, Vilmundur , Khosla, Sundeep , Harris, Tamara B. , Lang, Thomas , Cheng, Xiaoguang , Khosla, Sundeep

Journal of Bone and Mineral Research | October 29, 2012 | Volume: 28 | Issue: 3 | Pages: 537-546

10.1002/jbmr.1802 | PMID 23109068 Get It

Abstract Hip fracture risk rises exponentially with age, but there is little knowledge about how fracture-related alterations in hip structure differ from those of aging. We employed computed tomography (CT) imaging to visualize the three-dimensional (3D) spatial distribution of bone mineral density (BMD) in the hip in relation to age and incident hip fracture. We used intersubject image registration to integrate 3D hip CT images into a statistical atlas comprising women aged 21 to 97 years (n = 349) and a group of women with (n = 74) and without (n = 148) incident hip fracture 4 to 7 years after their imaging session. Voxel-based morphometry was used to generate Student's t test statistical maps from the atlas, which indicated regions that were significantly associated with age or with incident hip fracture. Scaling factors derived from intersubject image registration were employed as measures of bone size. BMD comparisons of young, middle-aged, and older American women showed preservation of load-bearing cortical and trabecular structures with aging, whereas extensive bone loss was observed in other trabecular and cortical regions. In contrast, comparisons of older Icelandic fracture women with age-matched controls showed that hip fracture was associated with a global cortical bone deficit, including both the superior cortical margin and the load-bearing inferior cortex. Bone size comparisons showed larger dimensions in older compared to younger American women and in older Icelandic fracture women compared to controls. The results indicate that older Icelandic women who sustain incident hip fracture have a structural phenotype that cannot be described as an accelerated pattern of normal age-related loss. The fracture-related cortical deficit noted in this study may provide a biomarker of increased hip fracture risk that may be translatable to dual-energy X-ray absorptiometry (DXA) and other clinical images. © 2013 American Society for Bone and Mineral Research.
Association of the PDYN gene with alcohol dependence and the propensity to drink in negative emotional states
Karpyak, Victor M. , Winham, Stacey J. , Preuss, Ulrich W. , Zill, Peter , Cunningham, Julie M. , Walker, Denise L., Lewis, Kriste A., Geske, Jennifer R. , Colby, Colin , Hall‐Flavin, Daniel K., Loukianova, Larissa L., Schneekloth, Terry D. , Frye, Mark A. , Bazov, Igor , Heit, John A. , Bakalkin, Georgy , Mrazek, David A. , Abulseoud, Osama A. , Biernacka, Joanna M. , Winham, Stacey J , Karpyak, Victor , Bakalkin, Georgy , Geske, Jennifer

International Journal of Neuropsychopharmacology | October 29, 2012 | Volume: 16 | Issue: 5 | Pages: 975-985

10.1017/s1461145712001137 | PMID 23101464 Get It

AbstractSynthetic κ-opioid receptor (KOR) agonists induce dysphoric and pro-depressive effects and variations in the KOR (OPRK1) and prodynorphin (PDYN) genes have been shown to be associated with alcohol dependence. We genotyped 23 single nucleotide polymorphisms (SNPs) in the PDYN and OPRK1 genes in 816 alcohol-dependent subjects and investigated their association with: (1) negative craving measured by a subscale of the Inventory of Drug Taking Situations; (2) a self-reported history of depression; (3) the intensity of depressive symptoms measured by the Beck Depression Inventory-II. In addition, 13 of the 23 PDYN and OPRK1 SNPs, which were previously genotyped in a set of 1248 controls, were used to evaluate association with alcohol dependence. SNP and haplotype tests of association were performed. Analysis of a haplotype spanning the PDYN gene (rs6045784, rs910080, rs2235751, rs2281285) revealed significant association with alcohol dependence (p = 0.00079) and with negative craving (p = 0.0499). A candidate haplotype containing the PDYN rs2281285-rs1997794 SNPs that was previously associated with alcohol dependence was also associated with negative craving (p = 0.024) and alcohol dependence (p = 0.0008) in this study. A trend for association between depression severity and PDYN variation was detected. No associations of OPRK1 gene variation with alcohol dependence or other studied phenotypes were found. These findings support the hypothesis that sequence variation in the PDYN gene contributes to both alcohol dependence and the induction of negative craving in alcohol-dependent subjects.
Standardization of analysis sets for reporting results from ADNI MRI data
Wyman, Bradley T., Harvey, Danielle , Crawford, Karen , Carmichael, Owen , Cole, Patricia E., Crane, Paul K. , DeCarli, Charles , Fox, Nick C. , Gunter, Jeffrey L. , Hill, David , Killiany, Ronald , Pachaï, Chahin , Schwarz, Adam J. , Schuff, Norbert, Senjem, Matthew L. , Suhy, Joyce, Thompson, Paul M. , Weiner, Michael W. , Initiative, Alzheimer's Disease Neuroimaging, Hsiung, Ging‐Yuek Robin , Preda, Adrian , Jicha, Gregory A. , Ponto, Laura L. Boles , Bernstein, Matt A. , Jack, Clifford R. , Initiative, Alzheimer's Disease Neuroimaging, DeCarli, Charles , Preda, Adrian , Thompson, Paul M , Hsiung, Gink-Yuek , Senjem, Matthew L , Fox, Nick C , Harvey, Danielle J , Jicha, Gregory A

Alzheimer's & Dementia | October 27, 2012 | Volume: 9 | Issue: 3 | Pages: 332-337

10.1016/j.jalz.2012.06.004 | PMID 23110865 Get It

AbstractThe Alzheimer's Disease Neuroimaging Initiative (ADNI) three‐dimensional T1‐weighted magnetic resonance imaging (MRI) acquisitions provide a rich data set for developing and testing analysis techniques for extracting structural endpoints. To promote greater rigor in analysis and meaningful comparison of different algorithms, the ADNI MRI Core has created standardized analysis sets of data comprising scans that met minimum quality control requirements. We encourage researchers to test and report their techniques against these data. Standard analysis sets of volumetric scans from ADNI‐1 have been created, comprising screening visits, 1‐year completers (subjects who all have screening, 6‐ and 12‐month scans), 2‐year annual completers (screening, 1‐year and 2‐year scans), 2‐year completers (screening, 6‐months, 1‐year, 18‐months [mild cognitive impaired (MCI) only], and 2‐year scans), and complete visits (screening, 6‐month, 1‐year, 18‐month [MCI only], 2‐year, and 3‐year [normal and MCI only] scans). As the ADNI‐GO/ADNI‐2 data become available, updated standard analysis sets will be posted regularly.
Teleconcussion: An Innovative Approach to Screening, Diagnosis, and Management of Mild Traumatic Brain Injury
Vargas, Bert B., Channer, Dwight D., Dodick, David W. , Demaerschalk, Bart M.

Telemedicine and e-Health | October 26, 2012 | Volume: 18 | Issue: 10 | Pages: 803-806

10.1089/tmj.2012.0118 | PMID 23101482 Get It

Concussion awareness and management in sports have gained a great deal of attention in light of research illustrating the potentially devastating consequences of repeated traumatic brain injuries. In order to address this public health crisis, numerous states have passed legislation that mandates medical clearance before being eligible to return to play of concussed athletes by a qualified healthcare provider. As the number of qualified healthcare providers with expertise in the diagnosis and management of concussions remains very small, patient safety and the ability to fulfill these legislative return-to-play requirements present unique problems to rural communities without easy access to subspecialty care. Telemedicine is a possible means by which to address the needs of the rural student-athlete.
Robotic Intracorporeal Urinary Diversion: Ileal Conduit
Johnson, David C. , Castle, Erik P., Pruthi, Raj S. , Woods, Michael E.

Journal of Endourology | October 26, 2012 | Volume: 26 | Issue: 12 | Pages: 1566-1569

10.1089/end.2012.0447 | PMID 23102129 Get It

Long-term hearing outcomes following stereotactic radiosurgery for vestibular schwannoma: patterns of hearing loss and variables influencing audiometric decline
Carlson, Matthew L. , Jacob, Jeffrey T. , Pollock, Bruce E. , Neff, Brian A., Tombers, Nicole M. , Driscoll, Colin L. W., Link, Michael J.

Journal of Neurosurgery | October 26, 2012 | Volume: 118 | Issue: 3 | Pages: 579-587

10.3171/2012.9.jns12919 | PMID 23101446 Get It

Object The goals of this retrospective cohort study were as follows: 1) to describe the long-term prevalence and timing of hearing deterioration following low-dose (12- to 13-Gy marginal dose) stereotactic radiosurgery (SRS) for vestibular schwannoma (VS); and 2) to identify clinical variables associated with long-term preservation of useful hearing following treatment. Methods Patients with serviceable hearing who underwent SRS for VS between 1997 and 2002 were studied. Data including radiosurgery treatment plans, tumor characteristics, pre- and posttreatment pure tone average, speech discrimination scores, and American Academy of Otolaryngology–Head and Neck Surgery hearing class were collected. Time to nonserviceable hearing was estimated using the Kaplan-Meier method. Univariate and multivariate associations with time to nonserviceable hearing were evaluated using Cox proportional hazards regression models. Results Forty-four patients met the study criteria and were included. The median duration of audiometric follow-up was 9.3 years. Thirty-six patients developed nonserviceable hearing at a mean of 4.2 years following SRS. The Kaplan-Meier estimated rates of serviceable hearing at 1, 3, 5, 7, and 10 years following SRS were 80%, 55%, 48%, 38%, and 23%, respectively. Multivariate analysis revealed that pretreatment ipsilateral pure tone average (p < 0.001) and tumor size (p = 0.009) were statistically significantly associated with time to nonserviceable hearing. Conclusions Durable hearing preservation a decade after low-dose SRS for VS occurs in less than one-fourth of patients. Variables including preoperative hearing capacity and tumor size may be used to predict hearing outcomes following treatment. These findings may assist in pretreatment risk disclosure. Furthermore, these data demonstrate the importance of long-term follow-up when reporting audiometric outcomes following SRS for VS.
Resolution of Acute Onset Hemichorea–Hemiballismus After Treatment With Intravenous Tissue Plasminogen Activator
McCollum, David , Silvers, Scott M., Barrett, Kevin M. , Dawson, Stephanie

The Neurohospitalist | October 26, 2012 | Volume: 3 | Issue: 3 | Pages: 131-134

10.1177/1941874412464055 | PMID 24167646 Get It

Hyperkinetic movement disorders are uncommon after acute ischemic stroke. Since these movement disorders are rarely the initial manifestation of acute cerebral ischemia, their presence may result in diagnostic uncertainty or it may inappropriately delay intravenous thrombolytic therapy for ischemic stroke. Hemichorea–hemiballism (HC-HB) is one of the more frequently encountered hyperkinetic movement disorders occurring in conjunction with stroke. Although HC-HB may result from a stroke mimic, the acute onset should prompt rapid evaluation and consideration for the presence of stroke along with its time-dependent therapies including recombinant tissue plasminogen activator (rtPA). In this article, we describe a case of a patient with acute cerebral ischemia presenting clinically with HC-HB, who was given intravenous rtPA therapy despite an initially negative, early diffusion-weighted magnetic resonance imaging (MRI). Follow-up brain MRI performed 24 hours after the initiation of thrombolytic therapy confirmed acute infarction in the contralateral striatum. The patient had near-complete resolution of her HC-HB on discharge and had no complications related to the administration of intravenous rtPA.
Estrogens and Alzheimer disease risk
Henderson, Victor W. , Rocca, Walter A.

Neurology | October 26, 2012 | Volume: 79 | Issue: 18 | Pages: 1840-1841

10.1212/wnl.0b013e318271f88f | PMID 23100400 Get It

Lenalidomide-mediated enhanced translation of C/EBPα-p30 protein up-regulates expression of the antileukemic microRNA-181a in acute myeloid leukemia
Hickey, Christopher , Schwind, Sebastian , Radomska, Hanna S. , Dorrance, Adrienne M. , Santhanam, Ramasamy , Mishra, Anjali , Wu, Yue-Zhong, Alachkar, Houda , Maharry, Kati , Mrózek, Krzysztof , Eiring, Anna M. , Whitman, Susan P., Becker, Heiko , Perrotti, Danilo , Wu, Lai‐Chu , Zhao, Xi , Fehniger, Todd A. , Vij, Ravi , Byrd, John C. , Blum, William , Lee, L. James , Bloomfield, Clara D. , Garzon, Ramiro , Marcucci, Guido , Byrd, John C. , Nicolet, Deedra , Walker, Alison , Caligiuri, Michael A. , Fehniger, Todd A , Byrd, John C

Blood | October 26, 2012 | Volume: 121 | Issue: 1 | Pages: 159-169

10.1182/blood-2012-05-428573 | PMID 23100311 Get It

AbstractRecently, we showed that increased miR-181a expression was associated with improved outcomes in cytogenetically normal acute myeloid leukemia (CN-AML). Interestingly, miR-181a expression was increased in CN-AML patients harboring CEBPA mutations, which are usually biallelic and associate with better prognosis. CEBPA encodes the C/EBPα transcription factor. We demonstrate here that the presence of N-terminal CEBPA mutations and miR-181a expression are linked. Indeed, the truncated C/EBPα-p30 isoform, which is produced from the N-terminal mutant CEBPA gene or from the differential translation of wild-type CEBPA mRNA and is commonly believed to have no transactivation activity, binds to the miR-181a-1 promoter and up-regulates the microRNA expression. Furthermore, we show that lenalidomide, a drug approved for myelodysplastic syndromes and multiple myeloma, enhances translation of the C/EBPα-p30 isoform, resulting in higher miR-181a levels. In xenograft mouse models, ectopic miR-181a expression inhibits tumor growth. Similarly, lenalidomide exhibits antitumorigenic activity paralleled by increased miR-181a expression. This regulatory pathway may explain an increased sensitivity to apoptosis-inducing chemotherapy in subsets of AML patients. Altogether, our data provide a potential explanation for the improved clinical outcomes observed in CEBPA-mutated CN-AML patients, and suggest that lenalidomide treatment enhancing the C/EBPα-p30 protein levels and in turn miR-181a may sensitize AML blasts to chemotherapy.